USD 70.83 billion
Report ID:
SQMIG35A2534 |
Region:
Global |
Published Date: September, 2024
Pages:
219
|Tables:
94
|Figures:
75
Global Medical Device Contract Manufacturing Market size was valued at USD 70.83 billion in 2023 and is poised to grow from USD 78.9 billion in 2024 to USD 187.15 billion by 2032, growing at a CAGR of 11.4% during the forecast period (2025-2032).
The medical device contract manufacturing market for medical devices is experiencing robust growth, driven by increased demand for the medical devices and technological advancements in the market has shown resilience and recovery, with a significant increase in the outsourcing of medical devices. The increase is driven by higher demand for devices such as ventilators and COVID-19-related products, putting companies in touch with contractors for their expertise and capabilities. The medical device contract manufacturing market with its diverse range of devices and product lines drives the demand for contract manufacturing services.
Companies that do not have in-house manufacturing facilities are turning into more contract manufacturers, fueling market growth. The initiatives taken to widen the acceptance and usage of medical devices across the globe, such as new regulatory framework and strategic approach also contribute to the market expansion. The in vitro diagnostic (IVD) device segment is poised to hold a significant share of the market demand for providing point-of-care devices is increasing. The market is driven by accessibility and expansion by key market players in North America, especially the US, as a key contributor to the market.
US Medical Device Contract Manufacturing Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 70.83 billion
Largest Segment
IVD devices
Fastest Growth
Patient monitoring devices
Growth Rate
11.4% CAGR
To get more reports on the above market click here to Buy The Report
Global Medical Device Contract Manufacturing Market is segmented by Device Type, Product, Service, Therapeutic Area, End-use and region. Based on Device Type, the market is segmented into IVD Devices, Diagnostic Imaging Devices, Cardiovascular Devices, Drug Delivery Devices, Orthopedic Devices, Respiratory Care Devices, Ophthalmology Devices, Surgical Devices, Diabetes Care Devices, Dental Devices, Endoscopy & Laparoscopy Devices, Gynecology/Urology Devices, Personal Care Devices, Neurology Devices, Patient Monitoring Devices, Patient Assistive Devices and Other Devices. Based on Product, the market is segmented into Class I, Class Ii and Class Iii. Based on Service, the market is segmented into Device Development and Manufacturing, Quality Management, Packaging And Assembly Services and Other Services. Based on Therapeutic Area, the market is segmented into Cardiovascular Devices, Orthopedic Devices, Ophthalmic Devices, Diagnostic Devices, Respiratory Devices, Surgical Instruments, Dental and Others. Based on End-use, the market is segmented into Original Equipment Manufacturers (OEMs), Pharmaceutical & Biopharmaceutical Companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The pharmaceutical and biopharmaceutical companies segment dominated the market in 2023 with a revenue share of 55.6%. Many biotechnology and pharmaceutical companies such as Bristol-Myers Squibb (BMS), GlaxoSmithKline, Novartis, Eli Lilly & Co., AstraZeneca invest in synthetic devices. The market has grown exponentially to introduce new product categories, such as vaccines, nanobodies, rDNA, immunoconjugates, soluble receptors, and immunotherapy. As biologics have revolutionized the treatment of diseases, the industry presents numerous opportunities to explore hybrid systems that blend biologics with well-defined drugs. Pharmaceutical and biopharmaceutical companies are therefore increasingly offering biotechnology contracts to CMOs, increasing the growth of the segment.
The medical device companies segment posted a substantial CAGR of 9.4% from 2024 to 2031. Electronics, material science, & software solutions, rising medical-device therapies have driven shift in paradigms in medical device contract manufacturing market competition. The above factors increased the cost of internal production, thereby outsourcing to industry specialists enabled the market players to concentrate their expertise majors and offered quality products at affordable costs. Stricter regulations and increased the cost pressures have a significant impact on medical device industry. The development of high-quality and safe devices for patient care is a major concern for medical device manufacturers. Additionally, the medical device regulatory landscape is vast and complex due to the regulatory and technical issues. As a result, firms are shifting their focus to innovation rather than non-core activities, and outsourcing has enabled market actors to reduce the risks.
Class II medical devices held the largest market share of 81.34% in 2023 and the segment is expected to register the fastest CAGR of 14.0% during the forecast period due to high cost of medical devices. The category includes catheters, syringes, surgical gloves, blood pressure monitors, pregnancy test kits, spectacles, and blood samples. These devices carry a higher risk than Class I devices because they must be in constant contact with patients. OEMs that manufacture Class II equipment often require contractors who can provide valuable services, such as technical support, legal support, and supply chain management. This segment provides a difference between contract manufacturers, as they must coordinate closely with OEMs to ensure compliance and quality control.
Class I medical devices are also expected to witness significant growth during the forecast period. These devices are non-invasive. Currently 47.0% of devices fall into this category and 95.0% of devices in this category are exempt due to low risk. Class I devices are easier and faster to buy from the market due to low risk for patient therefore and rarely life-threatening ongoing care. Class I devices are considered low-risk medical devices that cause minimal harm to users. These items include simple equipment and devices, such as bandages, hearing aids, tongue dressings and hospital beds. Class I machine tools are subject to less stringent regulatory requirements, such as good manufacturing processes (GMPs) and other controls. This simplifies the manufacture of Class I devices, allowing contractors to manufacture them efficiently with minimal financial regulatory burden.
To get detailed analysis on other segments, Request For Free Sample Report
North America dominated the medical device contract manufacturing market share in 2023 with 36.1% revenue. Notably, there are many established biotechnology, pharmaceutical and medical device companies. In addition, increasing R&D investments by life sciences and pharmaceutical companies are expected to increase the sector's demand for contract manufacturing independently. Strict regulation manufacturing and quality issues are also expected to provide opportunities for growth in medical device contract manufacturing.
Asia-Pacific is expected to witness a profitable growth rate of 10.6% during the forecast period due to improving healthcare infrastructure and economic growth in developing countries. This can be attributed to supportive regulatory changes, especially in countries like India, and cost-saving opportunities in Asian countries. Moreover, cGMP-compliant areas are expected to be established market players in the region will boost the market. Moreover, China is a major producer of low-cost electronics and goods. Therefore, it is expected to attract a significant number of investors. Furthermore, labor flexibility is greater in Asia Pacific due to lower production costs, tax advantages and availability of relatively cheap skilled labor but differences in time zones, cultures, speech and intellectual property rights in may restrain the growth of the market.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Growing Demand for Medical Devices
Increasing Outsourcing in the Healthcare Sector
Regulatory Compliance and Quality Control Challenges
Supply Chain Disruptions
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape of the medical device contract manufacturing market is composed of a wide variety of players including established companies, specialty contractors and emerging companies. These companies compete based on their technological expertise, manufacturing capabilities, regulatory compliance, and ability to provide end-to-end services, from product design to production and post-market support. Strategic partnerships, mergers and acquisitions, and investment in cutting-edge technologies are common strategies used by key players to maintain a competitive edge in this rapidly evolving market.
Technological Advances in Manufacturing:
Increased Focus on Sustainability and Environmentally Friendly Practices:
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to SkyQuest analysis, contract manufacturing of medical devices is experiencing strong growth, driven by increasing demand for medical devices, increasing exports OEMs are relying on contract manufacturers to consume production and meet the requirements and focus on other areas. However, regulatory challenges and supply chain disruptions are severely hampering the growth of the market. Technological advances and sustainability efforts represent key trends shaping the future of the industry. As contract manufacturers continue to innovate and adopt more flexible business models, they are well positioned to play a key role in global healthcare.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 70.83 billion |
Market size value in 2032 | USD 187.15 billion |
Growth Rate | 11.4% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Medical Device Contract Manufacturing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Medical Device Contract Manufacturing Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Medical Device Contract Manufacturing Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Medical Device Contract Manufacturing Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Medical Device Contract Manufacturing Market size was valued at USD 70.83 Billion in 2023 and is poised to grow from USD 78.9 Billion in 2024 to USD 187.14 Billion by 2032, growing at a CAGR of 11.4% during the forecast period (2025-2032).
The competitive landscape of the medical device contract manufacturing market is composed of a wide variety of players including established companies, specialty contractors and emerging companies. These companies compete based on their technological expertise, manufacturing capabilities, regulatory compliance, and ability to provide end-to-end services, from product design to production and post-market support. Strategic partnerships, mergers and acquisitions, and investment in cutting-edge technologies are common strategies used by key players to maintain a competitive edge in this rapidly evolving market. 'Jabil Inc. (US) ', 'Flex, Ltd. (US) ', 'Plexus Corp. (US) ', 'Integer Holdings Corporation (US) ', 'Celestica Inc. (Canada) ', 'West Pharmaceutical Services, Inc. (US) ', 'Benchmark Electronics Inc. (US) ', 'Kimball Electronics, Inc. (US) ', 'Nortech Systems, Inc. (US) ', 'Phillips-Medisize Corporation (US) ', 'Tessy Plastics Corp. (US) ', 'Tekni-Plex (US) ', 'Recipharm AB (Sweden) ', 'Gerresheimer AG (Germany) ', 'Carclo PLC (UK) ', 'Nemera (France) ', 'SMC Ltd. (UK) ', 'Sanmina Corporation (Japan) ', 'Nipro Corporation (Japan) ', 'NOLATO GW, Inc. (NOLATO AB) (Sweden) ', 'Mehow (Japan)'
Increasing demand for medical devices arising from increasing incidence of chronic diseases, aging population and advancement in healthcare is a major driver of the medical device contract manufacturing market. Growing demand for new high-end equipment and original equipment manufacturers (OEMs) collaborate with contractors to increase productivity and reduce costs. This collaborative effort that also draws attention building on similar core competencies enables faster production timelines and enhances world-class medical technology.
The adoption of advanced manufacturing technologies such as automation, 3D printing, and robotics is revolutionizing medical device contract manufacturing. These innovations increase, lower production, accuracy time, permitting cost-powerful customization of the medical devices. For instance, 3D printing permits rapid prototyping and production of complex scientific tool parts, at the same time as automation guarantees steady and scalable product quality and increases innovation and efficiency in the medical device contract manufacturing industry.
North America dominated the medical device contract manufacturing market share in 2023 with 36.1% revenue. Notably, there are many established biotechnology, pharmaceutical and medical device companies. In addition, increasing R&D investments by life sciences and pharmaceutical companies are expected to increase the sector’s demand for contract manufacturing independently. Strict regulation manufacturing and quality issues are also expected to provide opportunities for growth in medical device contract manufacturing.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35A2534
[email protected]
USA +1 351-333-4748